Heather Dellorfano
Overview
Explore the profile of Heather Dellorfano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Zaria M, Buckley L, Dellorfano H, Manzo P, Fanikos J
J Thromb Thrombolysis
. 2024 Mar;
57(4):598-602.
PMID: 38554223
Moderate-strong CYP3A4 or Pgp inhibitors and inducers alter direct oral anticoagulant (DOAC) pharmacokinetics. Whether the presence of a DOAC drug-drug interaction (DDI) prompts in- hospital changes in management remains unknown....
2.
Corcoran D, Kovacevic M, Dellorfano H, Sylvester K, Connors J
Crit Pathw Cardiol
. 2024 Jan;
23(3):159-165.
PMID: 38285539
Introduction: Brigham and Women's Hospital historically used titratable weight-based heparin nomograms with as needed boluses managed by extracorporeal membrane oxygenation specialists to achieve a predetermined goal-activated partial thromboplastin time (aPTT)....
3.
Fanikos J, Tawfik Y, Almheiri D, Sylvester K, Buckley L, Dew C, et al.
Am J Med
. 2023 May;
136(9):927-936.e3.
PMID: 37247752
Purpose: Anticoagulants often cause adverse drug events (ADEs), comprised of medication errors and adverse drug reactions, in patients. Our study objective was to determine the clinical characteristics, types, severity, cause,...
4.
Alsowaida Y, Kovacevic M, Belisle C, Cotugno M, Cooley T, Matta L, et al.
Hosp Pharm
. 2022 May;
57(2):211-216.
PMID: 35601721
Executive Quality and Safety WalkRounds (EWRs) is a tool that engages department leadership in discussion with the front-line employees to solicit feedback to improve quality and safety. The purpose of...
5.
Marino K, Crowley K, Tran L, Sylvia D, Dellorfano H, DeGrado J, et al.
Am J Health Syst Pharm
. 2021 Apr;
78(13):1200-1206.
PMID: 33821921
Purpose: Based on the pharmacokinetic profile of levothyroxine, a 3-day hold guideline for adult patients ordered for intravenous (IV) levothyroxine was implemented at a tertiary academic medical center. The purpose...
6.
Tran L, Anger K, Dellorfano H, Rocchio M, Szumita P
J Pharm Pract
. 2020 Jul;
34(6):908-912.
PMID: 32638650
Objective: To evaluate the cost, workflow, and safety of implementing a vial transfer device system. Methods: In this retrospective analysis, pharmacy systems and electronic health record reports identified high-volume and...
7.
Kelly J, Szumita P, Rocchio M, Palazzo C, Dellorfano H
Am J Health Syst Pharm
. 2019 Mar;
76(7):413-414.
PMID: 30852597
No abstract available.
8.
Cook B, Carter D, Dellorfano H, Matta L
Crit Pathw Cardiol
. 2017 Nov;
16(4):158-160.
PMID: 29135624
Potassium supplementation can be administered intravenously or orally with either immediate release or sustained release formulations. Sustained release potassium chloride allows for delayed absorption and peak effects. In the inpatient...
9.
Terry K, Buckley L, Aldemerdash A, Fanikos J, Dellorfano H
Cardiovasc Hematol Disord Drug Targets
. 2017 Sep;
17(2):132-135.
PMID: 28891451
Background: Ultrasound-assisted, catheter-directed thrombolysis (UA-CDT) relieves right ventricular stress without a significant increase in the risk of bleeding compared to systemic thrombolysis. Although concomitant anticoagulation is provided to prevent thrombus...
10.
Aday A, Dellorfano H, Hirning B, Matta L, OBrien M, Scirica B, et al.
Eur Heart J Acute Cardiovasc Care
. 2013 Dec;
2(4):299-305.
PMID: 24338288
Background: Intravenous sedation and analgesia are important therapies during mechanical ventilation (MV). However, daily interruption of these medications is associated with improved outcomes in mechanically ventilated patients. We tested a...